tried MASH for 10 weeks. here is what happened.
Genuinely asking, not being difficult.
Everyone in c/intlshipping repeats that biopsy is important. I believe it, but I have never seen anyone show why, and when I search I get 18 threads of people agreeing with each other.
Is there a paper? Is there a measurement? Or is this one of those things that is true because it has been repeated since 2023?
I am not trying to be the "source?" guy. I would just like a source.
best — the order this archive was captured in
Mechanistically the bit that matters is hepatic fat. It explains most of the early profile and a decent chunk of the outcome.
okay but what dose
Disagree on that part. 98.7% and 99.3% on the same vial is normal.
This is correct. Do not generalise from tirzepatide.
Respectfully this is a sample of one presented as a finding.
I love that this community will spend 40 comments on a detail. That pedantry is why the numbers here matter.
The thing nobody prepared me for was the quiet. Not the appetite, the quiet. The constant negotiation in my head about food just stopped.
The thing nobody prepared me for was the quiet.
Adding to this: hepatic fat is doing more work than the comment implies.
the heart rate signal is real in the data
the safety profile is not just tirzepatide amplified
Removed a chain here. The rule is one line long and it is not negotiable.
Removed a chain here.
Adding to this: hepatic fat is doing more work than the comment implies.
the MASH indication changes the risk calculus
This is correct. Do not generalise from tirzepatide.
- 1I love that this community will spend 40 comments on a detail. That pedantry…11 comments in this branch · started by u/employer_carveout
- 2okay but what dose4 comments in this branch · started by u/clara_restrepo